Legend Capital, a venture capital firm headquartered in Beijing, China, focuses on early-stage and growth-stage investments in innovative and high-growth enterprises primarily within China or related to China. Their strategy involves investing across sectors such as technology, healthcare, consumer, enterprise services, and intelligent manufacturing, while providing strategic guidance and operational support to their portfolio companies.
Deal activity increased 150% year-over-year (5 deals in the last 12 months). Average disclosed round size is $121.8M (across 18 rounds with reported amounts).
Portfolio
22
Fund Size
$10B
Top Stage
Series A
Last 12 Mo
5
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
22 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Viture | Series D | $100M | Feb 2026 |
 Obita | Series A | — | Jan 2026 |
| Obita | Seed | $30M | Jan 2026 |
| Obita | Seed | — | Dec 2025 |
| NNeolix | Series D | $600M | Oct 2025 |
 Angitia Biopharmaceuticals | Series C | $120M | Dec 2024 |
 Allink Biotherapeutics | Series A | $42M | Nov 2024 |
 Zhipu AI | Series B | — | Sep 2022 |
 ClinChoice | Series E | $150M | Jul 2022 |
| MMediLink Therapeutics | Series B | $70M | Mar 2022 |
 Lynk Pharmaceuticals | Series B | $50M | Aug 2021 |
 Mathpresso | Series C | $50M | Jul 2021 |
 Luckin Coffee | Series A | $200M | Dec 2018 |
 NewsDog | Series C | $50M | May 2018 |
 Innovent Biologics, Inc. | Series E | $150M | Apr 2018 |
 Pony.ai | Series A | $112M | Jan 2018 |
 Zuoyebang | Series A | — | Sep 2015 |
| Innovent Biologics, Inc. | Series C | $100M | Jan 2015 |
 Wish | Unknown | $50M | Jun 2014 |
 Happy Elements | Series B | $30M | Oct 2011 |
| IInceptio Technology | Series D | $188M | — |
 X Square Robot | Series D | $100M | — |
Top Co-Investors
Lilly Asia Ventures4 shared
Vision Plus Capital3 shared
Meituan3 shared
Sequoia China3 shared
Mirana Ventures2 shared
Monolith2 shared
Gaorong Capital2 shared
Temasek Holdings2 shared
GGV Capital2 shared
DCM Ventures2 shared
Legend Star2 shared
OrbiMed1 shared
Elikon Venture1 shared
Bertelsmann Group1 shared
Cormorant Asset Management1 shared
Rock Springs Capital1 shared
Ally Bridge Group1 shared
Hillhouse Capital1 shared
LYFE Capital1 shared
Loyal Valley Capital1 shared
Last updated: 12 April 2026